- Company
- Tests & Reagents
- Systems & Software
- Resources & Support
- Investors
- Product Catalog
Press Releases
2013
05/07/2013Cepheid Welcomes Executive Vice President of Global Operations
05/01/2013
Cepheid to Webcast Upcoming Financial Presentations
April
04/18/2013Cepheid Reports 2013 First Quarter Results
04/04/2013
Cepheid Schedules 2013 First Quarter Results Announcement And Webcast
February
02/19/2013Cepheid And Oregon Health & Science University Collaborate To Develop Oncology Assays For GeneXpert® System
02/14/2013
Cepheid Announces Board of Directors Changes
January
01/31/2013Cepheid to Webcast Upcoming Financial Presentations
01/24/2013
Cepheid Reports Fourth Quarter And Full Year 2012 Results
01/15/2013
Cepheid Announces Chlamydia and N. gonorrhoeae Test Categorized 'Moderate Complexity' by FDA
01/08/2013
Cepheid Announces Update On Xpert® Test Availability
2012
December
12/27/2012Cepheid Receives FDA Clearance for Xpert CT/NG, Delivering Rapid Detection and Differentiation of Chlamydia and N. gonorrhoeae
November
11/28/2012Cepheid to Webcast Upcoming Financial Presentations
11/05/2012
Cepheid Announces Executive Vice President Emerging Markets
October
10/25/2012Cepheid to Webcast Upcoming Financial Presentations
10/18/2012
Cepheid Reports 2012 Third Quarter Results
September
09/26/2012Cepheid Announces Preliminary 2012 Third Quarter Revenue Results
August
08/09/2012Cepheid to Webcast Upcoming Financial Presentations
08/06/2012
Cepheid Announces First Phase Of Xpert MTB/RIF Buy-Down For High Burden Developing Countries
July
07/25/2012Cepheid Announces Release of Updated Xpert BCR-ABL Monitor Test
07/19/2012
Cepheid Reports 2012 Second Quarter Results
07/09/2012
Cepheid Schedules 2012 Second Quarter Financial Results Announcement And Webcast
June
06/14/2012Cepheid Welcomes UNITAID Commitment To Broaden Access To "Ground-Breaking" Xpert® MTB/RIF
May
05/31/2012Cepheid to Webcast Upcoming Financial Presentations
05/24/2012
Cepheid Receives FDA Clearance for GeneXpert Infinity-80 System for Initial Use with Xpert Flu Assay
05/23/2012
Cepheid Announces European Release of Xpert CT/NG and Xpert CT, Delivering Rapid Detection and Differentiation of Chlamydia and Gonorrhoeae
April
04/26/2012Cepheid to Webcast Upcoming Financial Presentations
04/19/2012
Cepheid Reports 2012 First Quarter Results
04/19/2012
Cepheid Reports 2012 First Quarter Results
04/05/2012
Cepheid Schedules 2012 First Quarter Financial Results Announcement and Webcast
March
03/20/2012Cepheid Receives Grant to Develop Sample Processing and Amplification Methods for Detection of Bloodstream Bacteria
February
02/01/2012Cepheid to Webcast Upcoming Financial Presentations
January
01/26/2012Cepheid Reports Fourth Quarter and Full Year 2011 Results
01/17/2012
Cepheid Welcomes Senior Vice President of Human Resources
01/11/2012
Cepheid Schedules 2011 Fourth Quarter and Full Year Financial Results Announcement and Webcast
2011
December
12/01/2011Cepheid to Webcast Upcoming Financial Presentations
November
11/03/2011Cepheid to Webcast Upcoming Financial Presentations
October
10/20/2011Cepheid Reports 2011 Third Quarter Results
10/06/2011
Cepheid Schedules 2011 Third Quarter Financial Results Announcement and Webcast
September
09/14/2011Cepheid to Webcast Upcoming Financial Presentations
August
08/09/2011Cepheid Announces Release of Updated Xpert BCR-ABL Monitor TestCE IVD Test Now Delivers Results Aligned to the International Scale
08/03/2011
Cepheid to Webcast Upcoming Financial Presentations
July
07/21/2011Cepheid Reports 2011 Second Quarter Results
07/07/2011
Cepheid Schedules 2011 Second Quarter Financial Results Announcement and Webcast
June
06/28/2011Cepheid CEO John Bishop Named Ernst & Young Entrepreneur Of The Year® 2011 Northern California Award winner
May
05/12/2011Cepheid to Webcast Upcoming Financial Presentations
April
04/28/2011Cepheid to Webcast Upcoming Financial Presentations